Product
crenolanib
Aliases
CP-868,596-26
1 clinical trial
1 indication
Clinical trial
A Safety and Tolerability Trial of Crenolanib and Chemotherapy With Cytarabine and Anthracyclines in Patients With Newly Diagnosed Acute Myeloid Leukemia With FLT3 Activating MutationsStatus: Completed, Estimated PCD: 2019-12-01